The rates of influenza infection are highest among children, and children are most likely to be hospitalized for associated problems. Studies of flu vaccines in pediatric populations pose special challenges, due to the added safeguards and complex regulatory requirements.

This sponsor needed to conduct a pediatric influenza vaccine study – which was especially difficult as the timeline called for enrollment during the off-season months of March – May. With specialized expertise for pediatric trials, and extensive experience in vaccine trials, Quintiles was able to help this sponsor plan ahead – completing enrollment 3 months early and delivering a locked database 2.5 months ahead of schedule.